Intuitive Surgical Inc reported second-quarter 2026 results with revenue of $2.89B, net income of $818.1M and diluted EPS of $2.29, each rising sharply versus the year‑ago quarter as systems placements, recurring revenue and procedure volumes strengthened.
Financial Highlights
- Revenue was $2.89B, compared with $2.44B in the prior-year quarter; YoY change 18.6%.
- Net income was $818.1M, compared with $658.4M in the prior-year quarter; YoY change 24.3%.
- Diluted EPS was $2.29, compared with $1.81 in the prior-year quarter; YoY change 26.5%.
Business Highlights
- Total revenue rose 19% year over year to $2.89B in Q2, with recurring revenue representing roughly 85% of the mix, driven by instruments, service and operating leases.
- Systems placements increased 18% with 468 units placed; operating-lease placements accounted for about 54% of placements, lifting variable lease revenue.
- Procedure momentum continued: approximately 889K da Vinci procedures (up 15%) and about 47.9K Ion procedures (up 36%). Installed bases reached ~11,710 da Vinci systems and ~1,096 Ion systems.
- Operational progress included 246 da Vinci 5 placements in the quarter, expanded adoption of da Vinci 5/SP instruments, and multiple global regulatory clearances.
- Tariff volatility influenced costs during the period; the company received IEEPA tariff refunds, managed supply-chain risks and increased inventory to bolster resilience.
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.